| Michael B. Hoffman |
Michael B. Hoffman is the founder of Stone Capital Partners LLC, founded in 2018, where he holds the title of Partner. He is also the founder of Northern Genesis Acquisition Corp., founded in 2020, where he serves as President. In addition, he founded Northern Genesis Acquisition Corp. III in 2021 and held the title of President & Chief Executive Officer. Currently, Mr. Hoffman is the Chairman & Chief Executive Officer of Translational Development Acquisition Corp. since 2022. He is also the Chairman of Annovis Bio, Inc. since 2014. He holds director positions at Silver Ridge Power LLC, The Rockefeller University, Coastal Carolina Clean Power LLC, AG Global Canada LP, The Municipal Art Society of New York, Companhia Nacional de Acucar e Alcool, Manhattan Eye, Ear & Throat Hospital, Enviva LP, Sapphire Power Holdings LLC, Raven Power Finance LLC, AES Solar Energy Ltd., Curative, Inc., Northern Genesis Climate Solutions Corp., and International Institute For Nanotechnology. Previously, Mr. Hoffman served as Chairman of Traws Pharma, Inc. from 2006 to 2020. He held director positions at Green Earth Fuels LLC, Pattern Energy Group, Inc., Talen Energy Holdings, Inc., The Blackstone Group, Inc. (Illinois), Smith Barney Harris Upham & Co., Inc., Topaz Power Group LLC, Thermasource LLC, ReEnergy Holdings LLC, Talen Energy Corp., Enviva, Inc., Enviva Partners GP LLC, and Riverstone Holdings LLC. He was also a Partner at Riverstone Investment Group LLC. Additionally, he served as a Trustee at Northwell Health, Inc. and was the Head-Mergers & Acquisitions at Smith Barney & Co., Inc.Mr. Hoffman received his undergraduate and graduate degrees from Northwestern University. He also holds an MBA from Harvard Business School. |
| Melissa Gaines |
Melissa Gaines is currently working as the Senior Vice President-Clinical Operations at Annovis Bio, Inc. |
| Cheng Fang |
Cheng Fang is currently working as the Senior Vice President-Research & Development at Annovis Bio, Inc. Prior to this, Dr. Fang worked as the Manager-Business Development at Coriell Institute for Medical Research. |
| Henry Hagopian |
Henry Hagopian is currently the Chief Financial & Accounting Officer at Annovis Bio, Inc. He previously worked as a Treasury Manager at CIRCOR International, Inc. from 2005 to 2007. He also served as the Chief Financial Officer & Treasurer at Organogenesis Holdings, Inc. from 2020 to 2021. Mr. Hagopian completed his undergraduate degree at Fairleigh Dickinson University and holds graduate degrees, including an MBA, from the Wallace E Carroll School of Management. |
| Sarah MacCallum |
Ms. Sarah MacCallum is a Senior Clinical Director at Annovis Bio, Inc. She received her undergraduate degree from The Ohio State University and an undergraduate degree from St. Louis University. |
| Jeffrey B. McGroarty |
Jeffrey B. McGroarty is Chief Financial Officer of Annovis Bio, Inc. Mr. McGroarty is also on the board of People’s Light & Theatre Co. and Penn Mezzanine, Inc.
Mr. McGroarty previously occupied the position of Chief Financial Officer & Senior Vice President of Safeguard Scientifics, Inc., Vice President-Financial Planning at Exide Technologies, Inc., Senior Manager at PricewaterhouseCoopers LLP and Controller at Cephalon, Inc.
He received an undergraduate degree from The Pennsylvania State University and an MBA from The Wharton School of the University of Pennsylvania. |
| Maria-Luisa Maccecchini |
Maria-Luisa Maccecchini is the founder. She founded Annovis Bio, Inc. in 2008, where she currently holds the position of President, CEO, CFO & Director. She also founded Annovis, Inc. in 1992, where she served as Chief Executive Officer from 1992 to 2001. Dr. Maccecchini is also the founder of Message Pharmaceuticals, Inc. Dr. Maccecchini's current jobs include being an Independent Director at Treventis Corp., Lantern Pharma, Inc., and Translational Development Acquisition Corp. In her former positions, she worked as a Director at Protez Pharmaceuticals, Inc., Head-Molecular Biology at Mallinckrodt, Inc.(Old) and Mallinckrodt LLC, a Member at Robin Hood Ventures, and General Manager at Bachem Bioscience, Inc. She was also a Member of the Mid-Atlantic Angel Group from 2005 to 2013. Dr. Maccecchini obtained her doctorate degree from The Rockefeller University. |
| Claudine E. Bruck |
Claudine E. Bruck is the founder and currently holds the position of Chairman at Prolifagen LLC, which was founded in 2016. She is also currently serving as an Independent Director at Annovis Bio, Inc. since 2015 and as the Chief Scientific Officer at SapVax LLC. In her former positions, Dr. Bruck served as an Independent Director at Navidea Biopharmaceuticals, Inc. from 2018 to 2021. She also held the position of Course Director at the University of Pennsylvania, Head-Cancer Vaccine Program at GlaxoSmithKline LLC, and Assistant Professor at Tufts University School of Medicine. Dr. Bruck obtained a doctorate degree from Vrije Universiteit Brussel and a graduate degree from Harvard Medical School. |
| Reid S. McCarthy |
Reid S. McCarthy founded Atlantic Greenhouses, Inc., where he worked as President & Chief Executive Officer. Mr. McCarthy also currently works at Annovis Bio, Inc., as Independent Director from 2021. Mr. McCarthy also formerly worked at Chemical Bank Corp., as Principal, Trinity Capital Corp. (New Mexico), as Vice President-Financing, Topaz Pharmaceuticals, Inc., as Chief Financial Officer & Vice President from 2006 to 2010, Graphco Technologies, Inc., as Chief Financial Officer, Combustion Engineering, Inc., as Vice President from 1984 to 1991, and J.J. Haines & Co. LLC, as Chief Financial Officer. Mr. McCarthy received his Masters Business Admin degree from New York University and undergraduate degree from the University of New Hampshire. |
| Mark White |
Mark White is an Independent Director at Annovis Bio, Inc. since 2016. Prior to this, he was the Chief Executive Officer at NeuroKine Therapeutics LLC from 2015 to 2016 and Senior Director & Group Leader-Pain Therapeutics at Pfizer Inc. from 2002 to 2014. He also held the position of Senior Director-Marketing & Business Development at Bracco Diagnostics, Inc. Mr. White completed his undergraduate and graduate degrees from the University of Missouri and earned an MBA from The University of Chicago Booth School of Business. |
